IP Library Granted Patent US 9,744,156
Granted Patent B2
US 9,744,156 · App. 15/237,435 · Granted Aug 29, 2017

Methods and compositions for enhanced transungual delivery of AR-12

Inventors: Sathyanarayana Narasimha Murthy (Oxford, MS); Stefan Proniuk (Austin, TX)
Assignee: ARNO THERAPEUTICS, INC.
A61K31/415A61K9/0014A61K47/10A61K47/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,744,156
App. No.
15/237,435
Granted
Aug 29, 2017
Kind
B2
Abstract

Methods and compositions for enhancing transungual delivery of AR-12 comprising administering AR-12 and permeation enhancers are provided.

Claims (12)

1. A method of administering AR-12 to a nail comprising administering a composition comprising AR-12 and a permeation enhancer to a nail in an amount sufficient to achieve an AR-12 concentration of at least about 0.02 μg/mg in the nail plate.

2. The method of claim 1 , wherein the permeation enhancer is selected from the group consisting of dexpanthenol and polyethylene glycol 400.

3. The method of claim 2 , wherein the permeation enhancer comprises dexpanthenol and polyethylene glycol 400.

4. A method of administering AR-12 to a nail comprising administering a composition comprising AR-12 and a permeation enhancer to a nail in an amount sufficient to achieve a cumulative amount of AR-12 permeated across the nail plate of at least about 3 μg/cm2.

5. The method of claim 4 , wherein the permeation enhancer is selected from the group consisting of dexpanthenol and polyethylene glycol 400.

6. The method of claim 4 , wherein the permeation enhancer comprises dexpanthenol and polyethylene glycol 400.

7. A composition comprising AR-12 and dexpanthenol.

8. A composition comprising AR-12 polyethylene glycol 400.

9. A composition comprising AR-12 and dexpanthenol and polyethylene glycol 400.

10. The composition of claim 7 , wherein the concentration of dexpanthenol in the composition is about 5%.

11. The composition of claim 8 , wherein the concentration of polyethylene glycol in the composition is about 5%.

12. The composition of claim 9 , wherein the concentration of each of dexpanthenol and polyethylene glycol in the composition is about 5%.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 16, 2018
From: OHIO STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046548/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2018
From: ARNO THERAPEUTICS, INC.
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 044653/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2017
From: MURTHY, SATHYANARAYANA NARASIMHA; PRONIUK, STEFAN
To: ARNO THERAPEUTICS, INC.
Reel/Frame 042987/0189 →
Continuity (2)
Provisional Application 62206188 · Aug 17, 2015
Related Publication 20170049748A1 · Feb 23, 2017